MIKAYLA SOLLOWAY: Open Payments
NPI 1174270086 · SLINGERLANDS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 50 payments from 18 companies in 2025. Trend: 2023 $470 · 2024 $715 · 2025 $1,166
Food & beverage: $967Education: $199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $204 |
| Astellas Pharma US Inc | 2 | $199 |
| ABBVIE INC. | 10 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $148 |
| Lilly USA, LLC | 3 | $87 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Exact Sciences Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: JARDIANCE, Ozempic, QULIPTA, UBRELVY, MOUNJARO, Wegovy, VOQUEZNA, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
